As a promising synthetic peptide, Felypressin finds extensive applications in the realms of dental and medical procedures. Its vasoconstrictor properties enable efficacious mitigation of hemorrhages, thereby garnering immense attention for surgical and treatment interventions. Dentistry, in particular, embraces Felypressin fervently, harnessing its attributes as a potent local anesthetic to effectively address periodontal ailments and proffer optimum soothing for individuals enduring discomfort.
CAT No: R2009
CAS No:56-59-7
Synonyms/Alias:FELYPRESSIN;PLV-2;56-59-7;Felypressine;Felypressinum;Felipressina;Felipresina;Felipressina [DCIT];2-(L-Phenylalanine)-8-L-lysinevasopressin;Felipresina [INN-Spanish];Felypressine [INN-French];Felypressinum [INN-Latin];Phe(2)-Lys(8)-vasopressin;Felypressin [USAN:INN:BAN];DTXSID6048599;UNII-17N2918V6G;CHEBI:60564;EINECS 200-282-7;DTXCID6028525;Vasopressin, 2-L-phenylalanine-8-L-lysine-;17N2918V6G;(2S)-N-[(2S)-6-amino-1-[(2-amino-2-oxoethyl)amino]-1-oxohexan-2-yl]-1-[(4R,7S,10S,13S,16S,19R)-19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13,16-dibenzyl-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonyl]pyrrolidine-2-carboxamide;L-Cysteinyl-L-phenylalanyl-L-phenylalanyl-L-glutaminyl-L-asparaginyl-L-cysteinyl-L-prolyl-L-lysylglycinamide cyclic (1-6)disulfide;Felipresina (INN-Spanish);Felypressine (INN-French);Felypressinum (INN-Latin);FELYPRESSIN (MART.);FELYPRESSIN [MART.];1-{[(4R,7S,10S,13S,16S,19R)-19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13,16-dibenzyl-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-4-yl]carbonyl}-L-prolyl-L-lysylglycinamide;L-Cysteinyl-L-phenylalanyl-L-phenylalanyl-L-glutaminyl-L-asparaginyl-L-cysteinyl-L-prolyl-L-lysylglycinamide cyclic (1->6)disulfide;FELYPRESSIN (EP IMPURITY);FELYPRESSIN [EP IMPURITY];FELYPRESSIN (EP MONOGRAPH);FELYPRESSIN [EP MONOGRAPH];Phenylalanyl-Lysyl Vasopressin;Vasopressin, Phenylalanyl Lysyl;Lysine Vasopressin, Phenylalanine;Vasopressin, Phenylalanine Lysine;NCGC00182033-01;1-(((4R,7S,10S,13S,16S,19R)-19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13,16-dibenzyl-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-4-yl)carbonyl)-L-prolyl-L-lysylglycinamide;FELYPRESSIN [MI];FELYPRESSIN [INN];SCHEMBL33291;FELYPRESSIN [WHO-DD];PLV-2 (TN);CHEMBL3185126;SFKQVVDKFKYTNA-DZCXQCEKSA-N;HY-A0182;Tox21_112932;AKOS030529558;CS-5837;DB00093;CAS-56-59-7;DA-63405;FF138109;NS00033543;A12648;CYS-PHE-PHE-GLN-ASN-CYS-PRO-LYS-GLY-NH2 (1-6 DISULFIDE);CYS-PHE-PHE-GLN-ASN-CYS-PRO-LYS-GLY-NH2 (1-6 DISULPHIDE);(S)-N-((S)-6-amino-1-((2-amino-2-oxoethyl)amino)-1-oxohexan-2-yl)-1-((4R,7S,10S,13S,16S,19R)-19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13,16-dibenzyl-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-carbonyl)pyrrolidine-2-carboxamide;200-282-7;L-CYSTEINYL-L-PHENYLALANYL-L-PHENYLALANYL-L-GLUTAMINYL-L-ASPARAGINYL-L-CYSTEINYL-L-PROLYL-L-LYSYLGLYCINAMIDE CYCLIC (1->6)DISULPHIDE;
Chemical Name:(2S)-N-[(2S)-6-amino-1-[(2-amino-2-oxoethyl)amino]-1-oxohexan-2-yl]-1-[(4R,7S,10S,13S,16S,19R)-19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13,16-dibenzyl-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonyl]pyrrolidine-2-carboxamide
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More